Weeks Brad Allan: insider trades.
Weeks Brad Allan reported 12 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 8 open-market purchases ($18K) and 0 sales, across 1 company.
- Transactions
- 12
- Purchases (P)
- 8
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Weeks Brad Allan
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Vivos Inc (RDGL) | Officer · President | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Vivos Inc | P | 25,550 | $0.05 | 1,547,204 | Form 4 |
| 2026-08-10 | Vivos Inc | P | 50,000 | $0.05 | 1,521,654 | Form 4 |
| 2026-07-22 | Vivos Inc | P | 32,000 | $0.05 | 1,471,654 | Form 4 |
| 2026-07-21 | Vivos Inc | P | 60,000 | $0.05 | 1,439,654 | Form 4 |
| 2026-07-10 | Vivos Inc | P | 12,000 | $0.08 | 1,379,654 | Form 4/A |
| 2026-07-10 | Vivos Inc | P | 12,000 | $0.08 | 999,235 | Form 4 |
| 2026-07-09 | Vivos Inc | P | 48,000 | $0.08 | 1,367,654 | Form 4/A |
| 2026-07-09 | Vivos Inc | P | 48,000 | $0.08 | 987,235 | Form 4 |
| 2026-06-30 | Vivos Inc | A | 147,159 | $0 | 1,319,654 | Form 4/A |
| 2026-03-31 | Vivos Inc | A | 100,111 | $0 | 1,172,495 | Form 4/A |
| 2025-12-16 | Vivos Inc | A | 100,000 | $0 | 1,072,384 | Form 5 |
| 2025-10-01 | Vivos Inc | A | 33,149 | $0 | 972,384 | Form 5 |
Questions
What stock did Weeks Brad Allan buy or sell?
Weeks Brad Allan reported 12 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 8 open-market purchases ($18K) and 0 sales, across 1 company.
Is Weeks Brad Allan the same person as other filers with this name?
This page covers SEC CIK 2131351 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/weeks-brad-allan-2131351.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.